Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin + clopidogrel versus intravenous alteplase in acute minor stroke
IRCT20241016063386N3Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of aspirin, clopidogrel and tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Urmia University of Medical Sciences. Started Jul 2026; status: recruiting.
02
Drugs
aspirinclopidogreltissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20241016063386N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241016063386N3.